These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11218648)

  • 41. Characterization of modified antisense oligonucleotides in Xenopus laevis embryos.
    Lennox KA; Sabel JL; Johnson MJ; Moreira BG; Fletcher CA; Rose SD; Behlke MA; Laikhter AL; Walder JA; Dagle JM
    Oligonucleotides; 2006; 16(1):26-42. PubMed ID: 16584293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Valproic acid-induced somite teratogenesis in the chick embryo: relationship with Pax-1 gene expression.
    Barnes GL; Mariani BD; Tuan RS
    Teratology; 1996 Aug; 54(2):93-102. PubMed ID: 8948545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension.
    Phillips MI
    Hypertension; 1997 Jan; 29(1 Pt 2):177-87. PubMed ID: 9039099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antisense oligonucleotides inhibit in vitro cDNA synthesis by HIV-1 reverse transcriptase.
    Boiziau C; Tarrago-Litvak L; Sinha ND; Moreau S; Litvak S; Toulmé JJ
    Antisense Nucleic Acid Drug Dev; 1996; 6(2):103-9. PubMed ID: 8843324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of synthetic oligonucleotides for inhibition of factor NF-kappa B].
    Kozlov IA; Kubareva EA; Shabarova ZA
    Mol Biol (Mosk); 1998; 32(3):389-400. PubMed ID: 9720060
    [No Abstract]   [Full Text] [Related]  

  • 46. Somatic gene targeting with RNA/DNA chimeric oligonucleotides: an analysis with a sensitive reporter mouse system.
    Ino A; Yamamoto S; Kaneda Y; Kobayashi I
    J Gene Med; 2004 Nov; 6(11):1272-80. PubMed ID: 15459966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression.
    Mercatante DR; Kole R
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):126-32. PubMed ID: 12084454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Facilitating oligonucleotide delivery: helping antisense deliver on its promise.
    Gewirtz AM; Stein CA; Glazer PM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3161-3. PubMed ID: 8622906
    [No Abstract]   [Full Text] [Related]  

  • 49. [Impact of RelA antisense oligonucleotides on laryngeal carcinoma Hep-2 cell proliferation].
    Pan S; Wan J; Wu L; Zhao J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Dec; 24(24):1135-7. PubMed ID: 21395185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elucidation of gene function using C-5 propyne antisense oligonucleotides.
    Flanagan WM; Su LL; Wagner RW
    Nat Biotechnol; 1996 Sep; 14(9):1139-45. PubMed ID: 9631067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anxiogenic-like effect of corticotropin-releasing factor receptor 2 antisense oligonucleotides infused into rat brain.
    Isogawa K; Akiyoshi J; Tsutsumi T; Kodama K; Horinouti Y; Nagayama H
    J Psychopharmacol; 2003 Dec; 17(4):409-13. PubMed ID: 14870953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antisense oligonucleotides for target validation in the CNS.
    Ho SP; Hartig PR
    Curr Opin Mol Ther; 1999 Jun; 1(3):336-43. PubMed ID: 11713799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of antisense oligonucleotides to Cdx2 on the development of mouse embryos in vitro.
    Valcanis H; Kachab E; Haralambidis J; Beck F
    Int J Dev Biol; 1997 Apr; 41(2):375-8. PubMed ID: 9184347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. c-myc in vasculoproliferative disease.
    Edelman ER; Simons M; Sirois MG; Rosenberg RD
    Circ Res; 1995 Feb; 76(2):176-82. PubMed ID: 7834827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure, regulation and function of avian glypican.
    Niu S; Bahl JJ; Adamson C; Morkin E
    J Mol Cell Cardiol; 1998 Mar; 30(3):537-50. PubMed ID: 9515030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene therapy for hypertension: antisense inhibition with adeno-associated viral vector delivery targeting angiotensin II type 1-receptor messenger ribonucleic acid.
    Phillips MI
    Am J Cardiol; 1998 Nov; 82(10A):60S-62S. PubMed ID: 9860363
    [No Abstract]   [Full Text] [Related]  

  • 57. Reduction of liver tumor necrosis factor-alpha expression by targeting delivery of antisense oligonucleotides into Kupffer cells protects rats from fulminant hepatitis.
    Dong L; Zuo L; Xia S; Gao S; Zhang C; Chen J; Zhang J
    J Gene Med; 2009 Mar; 11(3):229-39. PubMed ID: 19189285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
    Boussif O; Lezoualc'h F; Zanta MA; Mergny MD; Scherman D; Demeneix B; Behr JP
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7297-301. PubMed ID: 7638184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of marker genes for pars tuberalis morphogenesis in chick embryo: expression of Cytokine-like 1 and Gap junction protein alpha 5 in pars tuberalis.
    Aizawa S; Higaki Y; Dudaui A; Nagasaka M; Takahashi S; Sakata I; Sakai T
    Cell Tissue Res; 2016 Dec; 366(3):721-731. PubMed ID: 27590887
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Study on the antisense inhibition effect of liposome-mediated radiolabled antisense oligonucleotides of c-myc mRNA].
    Zheng J; Tan T; Pan W; Zhang C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):413-6. PubMed ID: 12910676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.